September 2021 – content
Life Sciences
Acquisitions aid PerkinElmer's life science and cell and gene therapy ambitions
Manufacturer of protein and nucleic acid building blocks to join Danaher
Olink raises $265 million for biomarker identification technology
Cytiva and Pall to invest in manufacturing expansion
Tecan expands contract manufacturing capabilities with purchase
Biobank makes acquisitions
Cellink opens new markets with three further acquisitions
Purchases tilts AddLife towards clinical markets
Axion BioSystems bought by equity company
MOBILion names first SLIM product NIB
General Laboratory
UV-vis spectroscopy instrument wins funding
Nanalysis buys NMR software developer
Xenocs sells minority share for commercial development support
ACD/Labs enters AI partnership
Orochem signs global sales partner
Knauer opens offices in Austria and Switzerland
Process & hand-held instrumentation
First purchase order for 1st Detect’s ETD device
Geographic expansion of 908 Devices’ network
E+H continued infrastructure investments through 2020
Danaher makes nine acquisitions in the first half 2021
Ion Science launches wearable single gas detectors
Sensirion invests in start-up to fuel future pipeline
Financials
Virus testing continues to fuel AddLife Labtech
NGS tools market drives Twist Bioscience
Life Science unit leads G&H performance
Non-Covid bioprocessing growth in low double digits at Danaher LS
Covid demand drops at Qiagen in second quarter
Gene therapy reaches historic low at Takara Bio
Organic growth returns to PST, while Ingersoll adds further acquisitions
Healthcare only growing division at Nikon
Camlab sees export growth prevent sharper sales drop
PerkinElmer DAS sinks to 38% of total turnover
Olympus SSD to trump after challenging fiscal year
Indutrade MST back to growth
Agilent revenue growth not fuelled by pandemic demand
Medical and consumer segments drive Zeiss
Kewaunee hit by higher material costs
908 Devices ups guidance despite dipping top line
Industrial segment drives Varex rebound
Reported Ion Science revenues grow pre-pandemic
Danaher EAS recovers against weak first half 2020
All DT divisions expected to grow in second half of 2021
Slow recovery at Kromek
Appointments